These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice. Magnusson SE; Reimer JM; Karlsson KH; Lilja L; Bengtsson KL; Stertman L Vaccine; 2013 Mar; 31(13):1725-33. PubMed ID: 23384754 [TBL] [Abstract][Full Text] [Related]
7. A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations. Hessel A; Schwendinger M; Fritz D; Coulibaly S; Holzer GW; Sabarth N; Kistner O; Wodal W; Kerschbaum A; Savidis-Dacho H; Crowe BA; Kreil TR; Barrett PN; Falkner FG PLoS One; 2010 Aug; 5(8):e12217. PubMed ID: 20808939 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus. Di Mario G; Soprana E; Gubinelli F; Panigada M; Facchini M; Fabiani C; Garulli B; Basileo M; Cassone A; Siccardi A; Donatelli I; Castrucci MR Pathog Glob Health; 2017 Mar; 111(2):69-75. PubMed ID: 28081672 [TBL] [Abstract][Full Text] [Related]
9. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase. Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746 [TBL] [Abstract][Full Text] [Related]
10. Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses. Chavan R; Marfatia KA; An IC; Garber DA; Feinberg MB J Virol; 2006 Aug; 80(15):7676-87. PubMed ID: 16840346 [TBL] [Abstract][Full Text] [Related]
11. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses. Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus. Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096 [TBL] [Abstract][Full Text] [Related]
17. Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines. Altenburg AF; van Trierum SE; de Bruin E; de Meulder D; van de Sandt CE; van der Klis FRM; Fouchier RAM; Koopmans MPG; Rimmelzwaan GF; de Vries RD Sci Rep; 2018 Apr; 8(1):6474. PubMed ID: 29692427 [TBL] [Abstract][Full Text] [Related]
18. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689 [TBL] [Abstract][Full Text] [Related]
19. Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins. Di Mario G; Sciaraffia E; Facchini M; Gubinelli F; Soprana E; Panigada M; Bernasconi V; Garulli B; Siccardi A; Donatelli I; Castrucci MR Pathog Glob Health; 2017 Mar; 111(2):76-82. PubMed ID: 28079473 [TBL] [Abstract][Full Text] [Related]
20. Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes. Smith G; Liu Y; Flyer D; Massare MJ; Zhou B; Patel N; Ellingsworth L; Lewis M; Cummings JF; Glenn G Vaccine; 2017 Sep; 35(40):5366-5372. PubMed ID: 28844407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]